Skip to main content
Journal of Lipid Research logoLink to Journal of Lipid Research
. 2009 Aug;50(8):1685–1691. doi: 10.1194/jlr.P900029-JLR200

Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the Atherosclerosis Risk in Communities Study[S]

Keri L Monda *,1, Christie M Ballantyne , Kari E North *,§
PMCID: PMC2724055  PMID: 19346332

Abstract

Evidence exists that increased levels of physical activity decrease the population burden of cardiovascular disease (CVD). Although risk factors for CVD, including plasma lipids and lipoproteins, have been associated with physical activity, studies including a sizeable number of minority participants are lacking. Our purpose was to interrogate the longitudinal effect of physical activity on plasma lipids and lipoproteins in the African American and white participants of the Atherosclerosis Risk in Communities (ARIC) Study. Nine years of follow-up data on 8,764 individuals aged 45–64 years at baseline were used in linear mixed-effects models to estimate the association between increases in baseline physical activity on mean change in HDL, LDL, total cholesterol, and triglyceride levels. Increases in the level of activity were associated with increases in HDL in all strata and decreases in triglycerides among white participants. Physical activity was associated with LDL in all women, while the association with total cholesterol was limited to African American women. This study is one of the few to investigate the effect of physical activity on lipids and lipoproteins in a race- and sex-specific manner. Overall our results highlight the importance of physical activity on plasma lipid profiles and provide evidence for novel differential associations.

Keywords: African American, ARIC, cholesterol, exercise, HDL, LDL, race effect, sex effect, triglyceride


It has been well established that higher levels of physical activity decrease the incidence of and mortality from cardiovascular disease (13). This decrease in risk has been shown in some instances to be independent of weight or body fat loss (46). A National Institutes of Health Consensus Development Panel (7) declared physical inactivity to be a major risk factor for cardiovascular disease (CVD), citing the noted improvement to HDL levels that has been associated with physical activity. There have been a number of both observational and experimental studies examining the relationship between physical activity and plasma lipids and lipoproteins. However, few of these studies have included a sizeable number of nonwhite participants, and data on racial and ethnic differences in the response of lipids to activity are sparse.

The purpose of this investigation was to assess the longitudinal effect of physical activity on plasma lipids and lipoproteins by race and gender. The Atherosclerosis Risk in Communities (ARIC) Study, a longitudinal, community-based cohort study designed to investigate the etiology of and risk factors for cardiovascular disease, is particularly well suited for our purpose. Not only does this large observational study have measures of cardiovascular risk factors over time and detailed measures of physical activity, but it also includes sufficient numbers of both African American and white men and women to perform subgroup analyses.

METHODS

Study population

The ARIC Study is a multi-center prospective investigation of atherosclerotic disease (8). White and African American men and women aged 45–64 years at baseline were recruited from four communities: Forsyth County, North Carolina; Jackson, Mississippi; suburban areas of Minneapolis, Minnesota; and Washington County, Maryland. A total of 15,792 individuals participated in the baseline examination in 1987–1989, with three triennial follow-up examinations. This study was approved by the institutional review board at each field center, and the analysis was approved by the University of North Carolina at Chapel Hill School of Public Health institutional review board on research involving human subjects. Informed consent was received by all subjects or their representatives.

Of the 15,792 participants at baseline, we excluded those self-reporting race other than white or African American, and nonwhite persons from Minneapolis and Washington County (n = 103). We further excluded individuals who reported taking cholesterol-lowering medication at any visit, as well as those who were diabetic at any visit. Prevalent type 2 diabetes was defined as the presence of any of the following: a fasting blood glucose level of ≥126 mg/dl (7.0 mmol/L); a nonfasting blood glucose level of ≥200 mg/dl (11.1 mmol/L); self-reported physician diagnosis of type 2 diabetes; or pharmacologic treatment of diabetes in the past two weeks. Finally, individuals with missing information on physical activity or model covariates were excluded. Final sample sizes were n = 3,456, 3,829, 626, and 853 for white men and women and African American men and women, respectively. For models analyzing LDL, final sample sizes were slightly smaller (n = 3,433, 3,821, 624, and 851).

Measures

Blood samples were collected following a fast of at least 8 h and sent to the ARIC Central Lipid Laboratory for processing. Total plasma cholesterol and triglycerides were determined by enzymatic methods, HDL was measured after dextran-magnesium precipitation, and the Friedewald equation (9) was used to calculate LDL in those with triglyceride levels under 400 mg/dl. Detailed information on these procedures is available elsewhere (8, 10). Blood chemistries were performed at the Central Chemistry Laboratory of the University of Minnesota, and blood lipid analyses were performed at the University of Texas, Houston.

Physical activity at baseline was derived from a slightly modified Baecke Physical activity questionnaire (11) in which participants were asked to report in an open-ended format the four sports or exercises in which they most frequently participated. They were then asked the h per week (<1.0; ≥1.0 and <2.0; ≥2.0 and <3.0; ≥3.0 and <4.0; ≥4.0) and months per year (<1.0; ≥1 and <4; ≥4 and <7; ≥7 and <10; ≥10) spent in each activity. Each of the 150 reported sports and exercises was assigned a specific metabolic equivalent (MET) value according to the Compendium of Physical Activities (12), where 1.0 MET is considered a resting metabolic rate obtained during quiet sitting. MET values were then multiplied by the time and proportion of the year spent for a final value in units of MET-minutes per week. For comparison we also calculated the MET-minutes per week spent in moderate (3.0–6.0 METs) to vigorous (>6.0 METs) activity, as well as in vigorous activity alone.

Baseline age was calculated as interview date minus birth date. Time between visits (in days) was calculated as visit 3 minus visit 1 date. Education was categorized as less than a high school education, high school graduate or some vocational education, and college educated or higher. Baseline smoking status was dichotomized as current versus former or never. Dietary variables were assessed using a semi-quantitative food frequency questionnaire (13). Weight was measured at all clinic visits to the nearest pound and height was measured without shoes to the nearest centimeter. Body mass index (BMI) was computed as weight (in kg) divided by height squared (in meters).

Statistical analysis

We used longitudinal linear mixed-effects models to estimate the effect of an increase in MET-minutes per week of sport or exercise physical activity at baseline on HDL, LDL, total cholesterol and triglycerides from all four visits. This model form allows us to take advantage of the multiple measures of lipids available in the data, yet account for the clustering inherent within individuals. Model fitting diagnostics suggested we model visit as a random slope which allows the effect of physical activity on lipids to vary by individual across time. We specified an unstructured variance-covariance matrix in which all variances and covariances are distinctly estimated. Graphical techniques were used to confirm linearity between dependent and independent variables.

Likelihood ratio tests were used to examine statistical interactions between both race and sex with physical activity on lipids by comparing −2 log likelihood χ2 between nested models with and without the cross-product terms. Significant effect measure modification was found in a number of models, thus all analyses are stratified by race and sex. Covariates included age, education, and smoking status at baseline, field center, and an indicator variable denoting visit. We also tested baseline and change in intake of total calories, total fat, carbohydrate, dietary cholesterol, keys score, and alcohol as covariates. However because they did not confound the association based on a change of estimate criterion, they were not included in the final models. Finally, we ran additional models excluding women on hormone replacement therapy and individuals using anti-hypertensive medications. Differences were not noted (results not shown).

Beta coefficients derived from models were multiplied by 180 in order to estimate the mean effect of a 180 MET-minute/week increase in sport or exercise physical activity on lipids over each visit period of approximately three years. 180 MET-minutes represents the addition of one 3-MET activity (e.g., walking for pleasure, weight lifting, or bowling) for 60 min per week or one 6-MET activity (e.g., playing basketball, hiking, or modern dance) for 30 min per week. All analyses were conducted using Stata (StataCorp, College Station, TX).

RESULTS

Table 1 presents baseline characteristics of ARIC participants stratified by race and sex. We observe that women have higher HDL and total cholesterol, while men have higher LDL and triglycerides. Further, African American men and women have substantially lower triglyceride levels than white men and women. We also note that African American men and women have lower total and moderate-to-vigorous sport and exercise physical activity than white men and women. However, African American men have higher vigorous physical activity than their white counterparts. Overall, the proportion of total sport and exercise physical activity classified as vigorous is 17–36%; the majority of activity is of moderate intensity. This middle-aged population is overweight, with mean BMIs for all groups greater than 25 kg/m2 (14, 15); African American women are on average obese, with a mean BMI of just over 30 kg/m2.

TABLE 1.

Baseline characteristics of study participants by race and sex

Men
Women
White African American White African American
Age (y) 54.6 ± 5.7 53.7 ± 6.0 53.7 ± 5.7 52.8 ± 5.7
Education level (%)
 Elementary 17.2 43.5 15.1 36.4
 Intermediate 39.3 26.1 50.8 30.4
 Advanced 43.5 30.4 34.1 33.2
Smokers (%) 25.2 39.6 25.2 26.0
BMI (kg/m2) 27.2 ± 3.9 27.1 ± 4.7 26.2 ± 5.2 30.2 ± 6.4
HDL (mg/dl) 43.3 ± 12.4 51.6 ± 17.1 58.6 ± 16.9 59.7 ± 17.7
LDL (mg/dl) 139.8 ± 35.2 137.0 ± 42.1 134.3 ± 39.1 135.5 ± 42.6
Total cholesterol (mg/dl) 210.5 ± 37.9 210.1 ± 43.9 216.7 ± 41.2 215.1 ± 44.3
Triglycerides (mg/dl) 140.7 ± 84.9 110.9 ± 82.6 119.7 ± 67.7 100.4 ± 55.3
Total sport PA (MET-min/wk) 95.2 ± 69.4 82.1 ± 70.7 75.6 ± 60.4 58.6 ± 51.9
Mod-vig sport PA (MET-min/wk) 92.0 ± 70.0 76.9 ± 70.1 74.4 ± 60.2 57.0 ± 52.2
Vig sport PA (MET-min/wk) 27.2 ± 54.8 29.5 ± 61.2 14.7 ± 40.8 9.7 ± 35.4

Continuous values are mean ± SD; Individuals with diabetes and/or on cholesterol-lowering medications excluded. BMI, body mass index; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; PA, physical activity; MET, metabolic equivalent; Mod-vig, moderate to vigorous; Vig, vigorous.

Age-adjusted mean between-visit changes in plasma lipids, BMI, and weight by race and sex are shown in Table 2. Mean time between visits was approximately 3 years (2.99 ± 0.22 for whites and 2.95 ± 0.38 for African Americans). Over time, HDL and LDL showed statistically significant decreases per visit interval for all race-sex groups, total cholesterol statistically significantly decreased for all except white women, and triglycerides statistically significantly increased for all except African American men. This latter increase was most marked in white women. Weight, and therefore BMI, also showed statistically significant increases per visit interval for all race-sex groups, particularly in women. Statistically significant differences between race-sex groups were noted for all risk factors.

TABLE 2.

Age-adjusted mean between-visit changes in CVD risk factors by race and sex

White men
African American men
White women
African American women
Nc Mean 95% CI N Mean 95% CI N Mean 95% CI N Mean 95% CI
HDL (mg/dl)a 4,233 −0.61 −0.82, −0.40 999 −0.92 −1.37, −0.47 4,996 −1.06 −1.25, −0.88 1,642 −1.09 −1.44, −0.75
LDL (mg/dl)b 4,156 −3.68 −4.20, −3.16 994 −4.67 −5.79, −3.54 4,950 −1.32 −1.78, −0.85 1,635 −2.93 −3.80, −2.07
Total cholesterol (mg/dl)b 4,238 −3.53 −4.07, −2.99 1,001 −5.61 −6.78, −4.43 5,000 −0.22 −0.71, 0.27 1,643 −3.49 −4.39, −2.58
Triglycerides (mg/dl)b 4,238 3.91 2.77, 5.06 1,001 −0.50 −2.98,1.98 4,999 11.44 10.41, 12.48 1,643 3.03 1.11, 4.94
BMI (kg/m2)b 4,240 0.37 0.33, 0.40 1,009 0.23 0.16, 0.30 5,004 0.57 0.55, 0.60 1,673 0.46 0.41, 0.51
Weight (lbs)b 4,240 1.97 1.77, 2.16 1,010 1.36 0.95, 1.77 5,004 2.70 2.53, 2.88 1,674 2.30 1.98, 2.62

Individuals with diabetes and those on cholesterol-lowering medications excluded. Values represent the mean change in risk factor per visit interval (approximately 3 years). CI, confidence interval; CVD, corononary vascular disease; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol; BMI, body mass index.

a

P < 0.01.

b

P < 0.001 for differences of 4 means between race-sex groups.

c

Numbers vary due to differing missing data.

Results of regression models estimating the effect on plasma lipids of a 180 MET-minute/week increase in sports or exercise physical activity are shown in Table 3. Physical activity is associated with increased HDL (increases ranged 2.96–4.85 mg/dl), where estimates reach statistical significance in all four race-sex groups. Physical activity is associated with decreased LDL only in women, particularly African American women (−3.97 and −10.55 mg/dl for whites and African Americans, respectively). To further investigate this finding, we looked at hormone replacement therapy (HRT) and menopausal status as potential explanatory variables. We found no difference when excluding women on HRT, but we found a statistically significant interaction for menopausal status and physical activity in both white (P < 0.0001) and African American (P < 0.001) women. Results of stratified analysis show that the association of a 180 MET-minute/week increase in physical activity on LDL is greater in menopausal women [−5.91 (−10.47, −1.35) for whites; −14.68 (−23.82, −5.53) for African Americans] than in those who have not yet undergone menopause [−3.33 (−6.66, 0.01) for whites; −3.50 (−14.32, 7.33) for African Americans]. Stratified results for total cholesterol were similar and more extreme in African American than in white women. We observe an association of physical activity with decreased total cholesterol levels only in African American women (−7.41 mg/dl). Statistically significant decreases in triglycerides are observed in association with increased physical activity in whites (−12.93 and −8.95 mg/dl for men and women, respectively); however, although decreased triglycerides are observed also in African Americans, they do not reach statistical significance. Results from models estimating the association of lipids with increased moderate-to-vigorous physical activity were similar, while associations with only vigorous physical activity tended to be more pronounced (see supplementary Table I).

TABLE 3.

Estimates from mixed regression models of the association of a 180 MET-minutes/week increase in baseline physical activity from sports/exercise with lipid parameters over each visit period of approximately three years

Men
Women
White African American White African American
HDL 2.96 (1.94, 3.99)a 4.41 (1.66, 7.82)a 4.85 (3.39, 6.30)a 3.49 (0.43, 6.54)a
LDL −0.03 (−2.74, 2.67) −1.46 (−8.78, 5.86) −3.97 (−7.09, −0.85)a −10.55 (−17.38, −3.72)a
Total cholesterol 0.22 (−2.72, 3.15) 1.54 (−6.07, 9.15) −1.48 (−4.74, 1.78) −7.41 (−14.57, −0.26)a
Triglyceride −12.93 (−19.67, −6.18)a −7.54 (−17.39, 2.30) −8.95 (−15.05, −2.85)a −4.63 (−14.55, 5.29)

β (95% confidence interval) × 180 MET-minutes/week shown. Models controlled for baseline age, education, smoking status, ARIC field center, and visit. HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol.

a

P < 0.05.

DISCUSSION

In this study we examined the relationship between increases in baseline level of sport or exercise physical activity and mean change in level of triglycerides and total, HDL, and LDL cholesterol per visit interval (∼3 years) over 12 years in a cohort of African American and white middle-aged men and women. Increases in the baseline level of activity were associated with increases in HDL in all participants and decreases in triglycerides in white participants. Physical activity was associated with LDL only in women and with total cholesterol only in African American women. We chose to look at the effect of an increase of 180 MET-minutes/week because this value is equal to an additional h per week of a 3-MET activity such as walking for pleasure, weight lifting, or bowling, or an additional 30 min per week of a 6-MET activity such as basketball, hiking, or modern dance. Our results mirror those found in prior longitudinal analyses of observational data in which associations are primarily limited to HDL and triglycerides. In the Amsterdam Growth and Health Study, Twisk et al. found that physical activity was positively related to HDL but not to total cholesterol (16). In the Cardiovascular Risk in Young Finns Study, change in physical activity over six years was inversely associated with change in serum triglycerides, but no association was found with HDL or total cholesterol (17). In CARDIA, Sternfeld et al. found an association between activity change and HDL (18), as did Young et al. in the Stanford Five-City Project (19). Similarly, in exercise training studies, increases of HDL and decreases in triglycerides are observed more frequently than decreases in either LDL or total cholesterol (20, 21). Meta-analyses of exercise-training studies found average increases in HDL of 1.2, 2.53, and 1.95 mg/dl and average decreases in triglycerides of 15.8 and 7.12 mg/dl (2224).

Our finding of sex-specific associations of activity on LDL are for the most part novel. However, in the HERITAGE Study using principal components analysis, Katzmarzyk and colleagues found that loadings were stronger for LDL and total cholesterol in women, suggesting some sex differences in the response of lipids to exercise (25). Some physiologic and metabolic factors that may influence an effect in women but not men include menopausal status and the use of HRT. While analyses excluding women on HRT did not show any differences, we did find that physical activity had a greater effect on LDL in women who were postmenopausal. In ARIC, 92% of whites and 96% of African Americans were postmenopausal by the fourth visit.

We found that, at baseline, African American men and women had higher HDL and lower triglyceride levels than white men and women. Similar racial differences have been cited in the NHANES sample (26) as well as others (27, 28). We also find that African Americans do not participate in as much sport and exercise physical activity as whites. Similarly, African American NHANES participants were significantly more likely to be physically inactive (from nonwork sources) than white participants (29, 30). Over the years of the survey, we found that while overall LDL and total cholesterol levels improved for all race/sex groups, triglycerides increased for all except African American men. These changes have been noted in other ARIC publications (31, 32) as well as in the populations from NHANES between 1960 and 2002 (33), the Minnesota Heart Survey (MHS) over 20 years (34), and the Framingham Heart Study (35). Presumably some of the decline is due to the increased use of lipid-lowering medications. However, some of the decline appears to be independent of drug use, as shown in our sample as well as analyses from the MHS (34).

Only limited data are available on ethnic differences in the response of lipids to activity. While the direction of effect was the same for whites and African Americans, the association between increased baseline activity and mean decrease in triglycerides per visit period was only statistically significant in whites. Although differences in statistical significance are largely due to lack of precision in our results (not only does ARIC have fewer African American participants, but whites have an average of 3.2 visits whereas African Americans have an average of 2.8 visits), we do observe an overall smaller effect size in African Americans. African American participants had lower triglyceride levels at all visits than white participants, and there is some, albeit limited, evidence that baseline lipid levels may influence the response to activity (20). Our results also suggest increased responsiveness of LDL to activity in African American versus white women, and decreases in total cholesterol with increasing activity only in African American women; results that have not been duplicated in the few other studies where ethnic differences were evaluated. In the HERITAGE Family Study, Ardern et al. found no ethnic differences in lipid response (36); however, in subgroup analyses by HDL subfraction, Leon et al. found a significantly greater mean increase in HDL2 in African American versus white participants (37), an analysis we were unable to replicate due to lack of data. In the CARDIA Study, correlations between change in activity and change in lipids were small and did not differ greatly between African American and white participants (18).

There is great heterogeneity in response of blood lipids to physical activity, and genetic variations likely contribute to these differences. Consequently, variability in our results may reflect differences among sub-populations as well as potential residual confounding from numerous life-style variables for which we were only partially able to control. Further, while participants were instructed to be in a fasting state, a single session of exercise has been shown to have an effect on plasma triglycerides for up to 24–48 h afterwards (38); thus, timing of blood sampling may also have played a role.

Controversy exists as to whether improvements in lipid profile from physical activity are independent of weight or body fat loss. In our analyses, we purposefully chose not to present results adjusted for BMI given BMI's role as an intermediate between physical activity and lipid parameters. Inappropriate control of intermediate variables is not a reliably valid technique for effect decomposition and can create spurious statistical associations resulting in incorrect and misleading inferences (3943). In fact, in models in which we controlled for BMI, we found that estimates were biased through, toward, and away from the null (see supplementary Table II). Clearly, this bias is unpredictable in both magnitude and direction. While these effects are difficult to tease apart using observational data, sophisticated techniques have been developed that allow for a greater understanding of effect decomposition, including marginal structural modeling or path analysis (4446). In this work, it was our intent to estimate the total effect and not to perform a mediation analysis. Results from experimental studies in which participants have undergone exercise training where body weight was held constant are mixed. Sopko et al. demonstrated independent and additive effects of weight loss and exercise on increased HDL (47), and Thompson et al. showed increased HDL levels in exercise-trained, weight-stable men over one year (48). However, in an exercise intervention conducted by Fonong et al., there was no change in HDL level when weight was kept constant (49). Changes in lipoproteins following a single bout of exercise are well reported and provide evidence for the hypothesis that activity independently influences the lipid profile (38).

This study has a number of limitations worth noting. First, physical activity was assessed via questionnaire, which is subject to recall and other biases, and cannot provide the same precision in measurement that one would achieve with an objective device. Nonetheless, for large epidemiologic surveys such as ARIC, the use of a questionnaire is the most feasible way to measure physical activity (50). Further, the Baecke questionnaire performs well, with high reliability and accurate assessment (11, 5153). Second, these results cannot be generalized to individuals with type 2 diabetes or those on cholesterol-lowering medications. It has been well documented that exercise training is beneficial for those with type 2 diabetes (54, 55), likely acting through one of a number of proposed mechanisms, including decreased systemic inflammation and decreased abdominal visceral fat accumulation (56). However, we excluded diabetic persons because of the effect diabetes can have on the lipoprotein profile and because drugs for the treatment of diabetes (e.g., thiazolidinediones and metformin) exert an effect on lipoproteins (57). Limitations in generalizability may also arise due to these data being drawn from four geographic communities, three for whites and two for African Americans.

Despite these limitations, the ARIC Study is a unique resource by which to evaluate the longitudinal association between physical activity and lipid measures. Not only is it a large biracial cohort that allows for estimation of race- and sex-specific effects with adequate precision, study investigators also utilized validated methods for the measurement of physical activity. These strengths, combined with careful attention to analytic methods, inform the literature examining differential effects of activity on lipid profiles.

In summary, in the ARIC Study, we confirm the benefits of physical activity on HDL and triglycerides seen in previous research. We also found an additional benefit of activity on reducing LDL in women, particularly African American women. Data from large prospective studies suggest that each 1 mg/dl increase in HDL is associated with significant reductions in risk of coronary heart disease of at least 2% and 3% in men and women, respectively (58), and there is substantial evidence that moderate levels of physical activity confer significant health benefits (7). Although there is considerable interindividual variability in the response to physical activity, and with the understanding that physical activity is not necessarily an easily modified behavior, these results and others provide further evidence for and highlight the importance of consistent activity on plasma lipid profiles.

Supplementary Material

Supplemental Data

Acknowledgments

The authors thank the staff and participants of the ARIC Study for their important contributions. The authors thank Dr. Christy Avery for her invaluable insights and assistance in preparing the manuscript.

Footnotes

Abbreviations:

ARIC
Atherosclerosis Risk in Communities
BMI
body mass index
CVD
cardiovascular disease
HRT
hormone replacement therapy
MET
metabolic equivalent
[S]

The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of two tables.

REFERENCES

  • 1.Barengo N. C., Hu G., Lakka T. A., Pekkarinen H., Nissinen A., Tuomilehto J. 2004. Low physical activity as a predictor for total and cardiovascular disease mortality in middle-aged men and women in Finland. Eur. Heart J. 25: 2204–2211 [DOI] [PubMed] [Google Scholar]
  • 2.Warburton D. E., Nicol C. W., Bredin S. S. 2006. Health benefits of physical activity: the evidence. CMAJ. 174: 801–809 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Haskell W. L., Lee I. M., Pate R. R., Powell K. E., Blair S. N., Franklin B. A., Macera C. A., Heath G. W., Thompson P. D., Bauman A. 2007. Physical activity and public health. Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 116: 1081–1093 [DOI] [PubMed] [Google Scholar]
  • 4.Lee I. M., Rexrode K. M., Cook N. R., Manson J. E., Buring J. E. 2001. Physical activity and coronary heart disease in women: is “no pain, no gain” passe? JAMA. 285: 1447–1454 [DOI] [PubMed] [Google Scholar]
  • 5.Hu G., Tuomilehto J., Silventoinen K., Barengo N., Jousilahti P. 2004. Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. Eur. Heart J. 25: 2212–2219 [DOI] [PubMed] [Google Scholar]
  • 6.Li T. Y., Rana J. S., Manson J. E., Willett W. C., Stampfer M. J., Colditz G. A., Rexrode K. M., Hu F. B. 2006. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation. 113: 499–506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Physical activity and cardiovascular health 1996. NIH consensus development panel. JAMA. 276: 241–246 [PubMed] [Google Scholar]
  • 8.Atherosclerosis Risk in Communities (ARIC) Study: design and objectives 1989. ARIC investigators. Am. J. Epidemiol. 129: 687–702 [PubMed] [Google Scholar]
  • 9.Friedewald W. T., Levy R. I., Fredrickson D. S. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499–502 [PubMed] [Google Scholar]
  • 10.Lipid and Lipoprotein Determinations 1987. Atherosclerosis Risk in Communities (ARIC) Study. Manual 8. National Heart Lung and Blood Institute (NIH) [Google Scholar]
  • 11.Baecke J. A., Burema J., Frijters J. E. 1982. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am. J. Clin. Nutr. 36: 936–942 [DOI] [PubMed] [Google Scholar]
  • 12.Ainsworth B. E., Haskell W. L., Whitt M. C., Irwin M. L., Swartz A. M., Strath S. J., O'Brien W. L., Bassett D. R., Jr, Schmitz K. H., Emplaincourt P. O., et al. 2000. Compendium of physical activities: an update of activity codes and MET intensities. Med. Sci. Sports Exerc. 32: S498–S504 [DOI] [PubMed] [Google Scholar]
  • 13.Willett W. C., Sampson L., Stampfer M. J., Rosner B., Bain C., Witschi J., Hennekens C. H., Speizer F. E. 1985. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am. J. Epidemiol. 122: 51–65 [DOI] [PubMed] [Google Scholar]
  • 14.National Heart Lung and Blood Institute Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults Web page. Accessed April 2008 at http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.htm [Google Scholar]
  • 15.WHO 1995. Physical status: the use and interpretation of anthropometry. Report of a WHO expert consultation. World Health Organization, Geneva: [PubMed] [Google Scholar]
  • 16.Twisk J. W., Kemper H. C., Mellenbergh G. J., van Mechelen W., Post G. B. 1996. Relation between the longitudinal development of lipoprotein levels and lifestyle parameters during adolescence and young adulthood. Ann. Epidemiol. 6: 246–256 [DOI] [PubMed] [Google Scholar]
  • 17.Raitakari O. T., Porkka K. V., Taimela S., Telama R., Rasanen L., Viikari J. S. 1994. Effects of persistent physical activity and inactivity on coronary risk factors in children and young adults. Cardiovascular Risk in Young Finns Study. Am. J. Epidemiol. 140: 195–205 [DOI] [PubMed] [Google Scholar]
  • 18.Sternfeld B., Sidney S., Jacobs D. R., Jr, Sadler M. C., Haskell W. L., Schreiner P. J. 1999. Seven-year changes in physical fitness, physical activity, and lipid profile in the CARDIA Study. Coronary artery risk development in young adults. Ann. Epidemiol. 9: 25–33 [DOI] [PubMed] [Google Scholar]
  • 19.Young D. R., Haskell W. L., Jatulis D. E., Fortmann S. P. 1993. Associations between changes in physical activity and risk factors for coronary heart disease in a community-based sample of men and women: the Stanford five-city project. Am. J. Epidemiol. 138: 205–216 [DOI] [PubMed] [Google Scholar]
  • 20.Leon A. S., Sanchez O. A. 2001. Response of blood lipids to exercise training alone or combined with dietary intervention. Med. Sci. Sports Exerc. 33: S502–S515(discussion S528–509) [DOI] [PubMed] [Google Scholar]
  • 21.Durstine J. L., Grandjean P. W., Cox C. A., Thompson P. D. 2002. Lipids, lipoproteins, and exercise. J. Cardiopulm. Rehabil. 22: 385–398 [DOI] [PubMed] [Google Scholar]
  • 22.Tran Z. V., Weltman A., Glass G. V., Mood D. P. 1983. The effects of exercise on blood lipids and lipoproteins: a meta-analysis of studies. Med. Sci. Sports Exerc. 15: 393–402 [PubMed] [Google Scholar]
  • 23.Halbert J. A., Silagy C. A., Finucane P., Withers R. T., Hamdorf P. A. 1999. Exercise training and blood lipids in hyperlipidemic and normolipidemic adults: a meta-analysis of randomized, controlled trials. Eur. J. Clin. Nutr. 53: 514–522 [DOI] [PubMed] [Google Scholar]
  • 24.Kodama S., Tanaka S., Saito K., Shu M., Sone Y., Onitake F., Suzuki E., Shimano H., Yamamoto S., Kondo K., et al. 2007. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch. Intern. Med. 167: 999–1008 [DOI] [PubMed] [Google Scholar]
  • 25.Katzmarzyk P. T., Leon A. S., Rankinen T., Gagnon J., Skinner J. S., Wilmore J. H., Rao D. C., Bouchard C. 2001. Changes in blood lipids consequent to aerobic exercise training related to changes in body fatness and aerobic fitness. Metabolism. 50: 841–848 [DOI] [PubMed] [Google Scholar]
  • 26.Mensah G. A., Mokdad A. H., Ford E. S., Greenlund K. J., Croft J. B. 2005. State of disparities in cardiovascular health in the United States. Circulation. 111: 1233–1241 [DOI] [PubMed] [Google Scholar]
  • 27.Howard B. V., Criqui M. H., Curb J. D., Rodabough R., Safford M. M., Santoro N., Wilson A. C., Wylie-Rosett J. 2003. Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal white, black, hispanic, and Asian/Pacific Islander women. Metabolism. 52: 362–371 [DOI] [PubMed] [Google Scholar]
  • 28.Kuller L. H.2004. Ethnic differences in atherosclerosis, cardiovascular disease and lipid metabolism. Curr. Opin. Lipidol. 15: 109–113 [DOI] [PubMed] [Google Scholar]
  • 29.Winkleby M. A., Kraemer H. C., Ahn D. K., Varady A. N. 1998. Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the third national health and nutrition examination survey, 1988–1994. JAMA. 280: 356–362 [DOI] [PubMed] [Google Scholar]
  • 30.Sundquist J., Winkleby M. A., Pudaric S. 2001. Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988–1994. Third national health and nutrition examination survey. J. Am. Geriatr. Soc. 49: 109–116 [DOI] [PubMed] [Google Scholar]
  • 31.Szklo M., Chambless L. E., Folsom A. R., Gotto A., Jr, Nieto F. J., Patsch W., Shimakawa T., Sorlie P., Wijnberg L. 2000. Trends in plasma cholesterol levels in the Atherosclerosis Risk in Communities (ARIC) study. Prev. Med. 30: 252–259 [DOI] [PubMed] [Google Scholar]
  • 32.Truesdale K. P., Stevens J., Cai J. 2007. Nine-year changes in cardiovascular disease risk factors with weight maintenance in the atherosclerosis risk in communities cohort. Am. J. Epidemiol. 165: 890–900 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Carroll M. D., Lacher D. A., Sorlie P. D., Cleeman J. I., Gordon D. J., Wolz M., Grundy S. M., Johnson C. L. 2005. Trends in serum lipids and lipoproteins of adults, 1960–2002. JAMA. 294: 1773–1781 [DOI] [PubMed] [Google Scholar]
  • 34.Arnett D. K., Jacobs D. R., Jr., Luepker R. V., Blackburn H., Armstrong C., Claas S. A. 2005. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980–1982 to 2000–2002. Circulation. 112: 3884–3891 [DOI] [PubMed] [Google Scholar]
  • 35.Sytkowski P. A., Kannel W. B., D'Agostino R. B. 1990. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N. Engl. J. Med. 322: 1635–1641 [DOI] [PubMed] [Google Scholar]
  • 36.Ardern C. I., Katzmarzyk P. T., Janssen I., Leon A. S., Wilmore J. H., Skinner J. S., Rao D. C., Despres J. P., Rankinen T., Bouchard C. 2004. Race and sex similarities in exercise-induced changes in blood lipids and fatness. Med. Sci. Sports Exerc. 36: 1610–1615 [DOI] [PubMed] [Google Scholar]
  • 37.Leon A. S., Rice T., Mandel S., Despres J. P., Bergeron J., Gagnon J., Rao D. C., Skinner J. S., Wilmore J. H., Bouchard C. 2000. Blood lipid response to 20 weeks of supervised exercise in a large biracial population: the Heritage family study. Metabolism. 49: 513–520 [DOI] [PubMed] [Google Scholar]
  • 38.Durstine J. L., Haskell W. L. 1994. Effects of exercise training on plasma lipids and lipoproteins. Exerc. Sport Sci. Rev. 22: 477–521 [PubMed] [Google Scholar]
  • 39.Kaufman J. S., Maclehose R. F., Kaufman S. 2004. A further critique of the analytic strategy of adjusting for covariates to identify biologic mediation. Epidemiol. Perspect. Innov. 1: 4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Robins J. M., Greenland S. 1992. Identifiability and exchangeability for direct and indirect effects. Epidemiology. 3: 143–155 [DOI] [PubMed] [Google Scholar]
  • 41.Hernan M. A., Hernandez-Diaz S., Werler M. M., Mitchell A. A. 2002. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am. J. Epidemiol. 155: 176–184 [DOI] [PubMed] [Google Scholar]
  • 42.Bulterys M., Morgenstern H. 1993. Confounding or intermediate effect? An appraisal of iatrogenic bias in perinatal AIDS research. Paediatr. Perinat. Epidemiol. 7: 387–394 [DOI] [PubMed] [Google Scholar]
  • 43.Weinberg C. R.1993. Toward a clearer definition of confounding. Am. J. Epidemiol. 137: 1–8 [DOI] [PubMed] [Google Scholar]
  • 44.Robins J. M., Hernan M. A., Brumback B. 2000. Marginal structural models and causal inference in epidemiology. Epidemiology. 11: 550–560 [DOI] [PubMed] [Google Scholar]
  • 45.Ditlevsen S., Christensen U., Lynch J., Damsgaard M. T., Keiding N. 2005. The mediation proportion: a structural equation approach for estimating the proportion of exposure effect on outcome explained by an intermediate variable. Epidemiology. 16: 114–120 [DOI] [PubMed] [Google Scholar]
  • 46.VanderWeele T. J.2009. Marginal structural models for the estimation of direct and indirect effects. Epidemiology. 20: 18–26 [DOI] [PubMed] [Google Scholar]
  • 47.Sopko G., Leon A. S., Jacobs D. R., Jr., Foster N., Moy J., Kuba K., Anderson J. T., Casal D., McNally C., Frantz I. 1985. The effects of exercise and weight loss on plasma lipids in young obese men. Metabolism. 34: 227–236 [DOI] [PubMed] [Google Scholar]
  • 48.Thompson P. D., Yurgalevitch S. M., Flynn M. M., Zmuda J. M., Spannaus-Martin D., Saritelli A., Bausserman L., Herbert P. N. 1997. Effect of prolonged exercise training without weight loss on high-density lipoprotein metabolism in overweight men. Metabolism. 46: 217–223 [DOI] [PubMed] [Google Scholar]
  • 49.Fonong T., Toth M. J., Ades P. A., Katzel L. I., Calles-Escandon J., Poehlman E. T. 1996. Relationship between physical activity and HDL-cholesterol in healthy older men and women: a cross-sectional and exercise intervention study. Atherosclerosis. 127: 177–183 [DOI] [PubMed] [Google Scholar]
  • 50.Matthews C. E.2002. Use of self-report instruments to assess physical activity. InPhysical Activity Assessments for Health-Related Research. Welk G. J., editor Human Kinetics, Champaign, IL: 107–123 [Google Scholar]
  • 51.Pols M. A., Peeters P. H., Bueno-De-Mesquita H. B., Ocke M. C., Wentink C. A., Kemper H. C., Collette H. J. 1995. Validity and repeatability of a modified Baecke questionnaire on physical activity. Int. J. Epidemiol. 24: 381–388 [DOI] [PubMed] [Google Scholar]
  • 52.Richardson M. T., Ainsworth B. E., Wu H. C., Jacobs D. R., Jr., Leon A. S. 1995. Ability of the Atherosclerosis Risk in Communities (ARIC)/Baecke questionnaire to assess leisure-time physical activity. Int. J. Epidemiol. 24: 685–693 [DOI] [PubMed] [Google Scholar]
  • 53.Philippaerts R. M., Westerterp K. R., Lefevre J. 1999. Doubly labelled water validation of three physical activity questionnaires. Int. J. Sports Med. 20: 284–289 [DOI] [PubMed] [Google Scholar]
  • 54.Sigal R. J., Kenny G. P., Wasserman D. H., Castaneda-Sceppa C., White R. D. 2006. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 29: 1433–1438 [DOI] [PubMed] [Google Scholar]
  • 55.Sigal R. J., Kenny G. P., Boule N. G., Wells G. A., Prud'homme D., Fortier M., Reid R. D., Tulloch H., Coyle D., Phillips P., et al. 2007. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann. Intern. Med. 147: 357–369 [DOI] [PubMed] [Google Scholar]
  • 56.Stewart K. J.2002. Exercise Training and the Cardiovascular Consequences of Type 2 Diabetes and Hypertension: Plausible Mechanisms for Improving Cardiovascular Health. J. Am. Med. Assoc. 288: 1622–1631 [DOI] [PubMed] [Google Scholar]
  • 57.Bolen S., Feldman L., Vassy J., Wilson L., Yeh H. C., Marinopoulos S., Wiley C., Selvin E., Wilson R., Bass E. B., et al. 2007. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann. Intern. Med. 147: 386–399 [DOI] [PubMed] [Google Scholar]
  • 58.Gordon D. J., Probstfield J. L., Garrison R. J., Neaton J. D., Castelli W. P., Knoke J. D., Jacobs D. R., Jr., Bangdiwala S., Tyroler H. A. 1989. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79: 8–15 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data
P900029-JLR200_1.pdf (61.2KB, pdf)

Articles from Journal of Lipid Research are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES